Jing He
Peking University People's Hospital · Peking University Institute of Rheuamotology and Immunology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jing He as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:21 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT07617740 · IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)Peking University People's Hospital · recruiting · REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS · principal investigator
- Ph2NCT06862284 · Therapeutic Effect of Upadacitinib in Primary Sjögren's SyndromePeking University People's Hospital · not yet recruiting · Primary Sjögren's Syndrome (pSS) · principal investigator
- Ph2NCT05998759 · Telitacicept for the Treatment of Connective Tissue Disease-associated ThrombocytopeniaBeijing Hospital · recruiting · Connective Tissue Diseases, Thrombocytopenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 72 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:21 UTC. The ranking covers the 200 most relevant of 937 PubMed records, and a shared surname and initials can bring in a namesake. All 937 on PubMed
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med · 20203,522 citationsRCR 201.4
- Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.N Engl J Med · 20201,582 citationsRCR 68.6
- 561 citationsRCR 18.1
- Perioperative Nivolumab in Resectable Lung Cancer.N Engl J Med · 2024535 citationsRCR 59.3
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.Cancer Cell · 2022462 citationsRCR 28.6
- Calorie Restriction with or without Time-Restricted Eating in Weight Loss.N Engl J Med · 2022412 citationsRCR 33.5
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.Ann Rheum Dis · 2020281 citationsRCR 12.5
- 251 citationsRCR 28.5
- Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study.Lancet Respir Med · 2019242 citationsRCR 8.5
- Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.JAMA Intern Med · 2016233 citationsRCR 8.7